FDA Issues Final Rule on CGMP for Combination Drug, Device & Biological Products
The Food and Drug Administration issued a final rule clarifying application of current good manufacturing practice (CGMP) requirements to combinations comprised of drugs, devices, and/or biological products. Depending on the form of combination, CGMP requirements will: (1) apply to each…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
constituent part separately; or (2) satisfy CGMP or quality system regulation requirements for another constituent part if applied to one constituent part. The final rule is effective July 21.